Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate for the Treatment of Metachromatic Leukodystrophy

News
2022
2021
Archive

August 11, 2022

Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate for the Treatment of Metachromatic Leukodystrophy
August 11, 2022

Nouscom Announces Leading Publication Revealing an Immune Mechanism of Action Driving Anti-Tumor Activity of Adenovirus Vectored Vaccines and Anti-PD1 Immunotherapy
August 10, 2022

Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst®
August 9, 2022

CCRM Fertility and TMRW Life Sciences to Expand Partnership Modernizing IVF Specimen Management Across All Locations
August 8, 2022

Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder
August 8, 2022

CinCor Pharma Announces Positive Topline Data for Phase 2 BrigHtn Trial Evaluating Baxdrostat, its Selective Aldosterone Synthase Inhibitor, in Treatment-Resistant Hypertension
August 3, 2022

Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder
August 3, 2022

Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors
August 3, 2022

Pear Therapeutics to be Added to Russell US Index Series
August 2, 2022

Arvinas Appoints John Northcott as Chief Commercial Officer

1
2
3
…
94
Next Page »

© 2022 5AM Venture Management LLC